RCC, Clear Cell Adenocarcinoma
2 clinical trials · Condition
◉ Watch RCC, Clear Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors (NCT05856981) | Sairopa B.V. | 2023-04-03 |
| A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) (NCT02974738) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-12-07 |
Track RCC, Clear Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.